🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. HTX-011

    Heron Therapeutics

    Postoperative Pain

    approved small molecule completed

    8 trials

  2. HTX-011

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    6 trials

  3. Haloperidol

    United Therapeutics Europe Ltd

    Migraine Headaches

    approved small molecule terminated

    1 trial

  4. Heliox inspirate

    United Therapeutics Europe Ltd

    Work of Breathing

    approved small molecule active

    1 trial

  5. Hemlibra 150 mg/mL solution for injection

    Hoffmann-La Roche

    Severe or Moderate Hemophilia A

    approved small molecule active

    1 trial

  6. Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient

    Biocodex

    Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))

    approved small molecule active

    1 trial

  7. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial

  8. Hylenex

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    2 trials

  9. Hypo-osmolar ORS

    United Therapeutics Europe Ltd

    Diarrhoea

    approved small molecule completed

    1 trial

  10. IPTACOPAN HYDROCHLORIDE, IPTACOPAN

    Novartis Pharmaceuticals

    C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis

    approved small molecule active

    1 trial

  11. IVC

    The First People's Hospital of Lianyungang

    Proliferative Diabetic Retinopathy

    approved small molecule active

    1 trial

  12. Imiquimod

    United Therapeutics Europe Ltd

    Lentigo Maligna

    approved small molecule completed

    1 trial

  13. Initiating daily oral PrEP during pregnancy

    United Therapeutics Europe Ltd

    Pre-exposure Prophylaxis

    approved small molecule active

    1 trial

  14. Intraosseous Morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    approved other active

    1 trial

  15. Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmias, Cardiac

    approved small molecule active

    1 trial

  16. Intravenous Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial

  17. Intravenous/Subcutaneous Treprostinil; Oral Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial

  18. Intravitreal Aflibercept Injection (IAI)

    Regeneron UK Limited

    Age - Related Macular Degeneration (AMD)

    approved small molecule completed

    1 trial

  19. Intravitreal Aflibercept Injection 2mg

    Regeneron UK Limited

    Neovascular Age-related Macular Degeneration

    approved small molecule active

    2 trials

  20. Intravitreal aflibercept injection

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  21. Isoniazid

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    2 trials

  22. Isotonic hydration fluid and recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  23. Isotretinoin

    VYNE Therapeutics

    Acne Vulgaris

    approved small molecule completed

    1 trial

  24. KENACORT 40 mg/ml sospensione iniettabile, Suero Fisiológico Braun 0,9% disolvente para uso parenteral Cloruro de sodio, Lidocaína B. Braun 20 mg/ml solución inyectable, BUPIVACAÍNA PHYSAN 0,25% SOLUCIÓN INYECTABLE

    The George Institute

    TRAPEZIUS MYOFASCIAL SYNDROME IN FIBROMYALGIA PATIENTS

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources